Measurement of the acid-labile subunit of the insulin-like growth factor binding protein complex in human serum: a comparison of four immunoassays

被引:8
作者
Baxter, RC [1 ]
Svejkar, M
Khosravi, MJ
Bennett, GL
Hardman, KV
Senese, A
Mistry, J
Walton, PE
Quarmby, V
机构
[1] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia
[2] Cooperat Res Ctr Diagnost Technol, Brisbane, Qld 4001, Australia
[3] Bioclone Australia Pty Ltd, Sydney, NSW 2204, Australia
[4] Diagnost Syst Labs Inc, Webster, TX 77598 USA
[5] Genentech Inc, BioAnalyt Technol, San Francisco, CA 94080 USA
关键词
D O I
10.1677/joe.0.1650271
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The acid-labile subunit (ALS) of the high molecular weight insulin-like growth factor binding protein complex is a liver-derived glycoprotein which is regulated by growth hormone and serves as a serum marker of growth hormone action. We have compared the measurement of ALS by four immunoassay methods (two RIAs, two ELISAs) utilizing various polyclonal and monoclonal antibodies raised against natural or recombinant human ALS, or synthetic ALS peptides. Despite the variety of methodologies and reagents, results obtained by the four methods were highly correlated for 125 sera from various patient groups, and when compared for individual groups of sera from healthy children and adults, growth hormone-deficient children and adults, and subjects with acromegaly. Some weaker correlations among methods were seen when measuring ALS levels in groups of sera from pregnant subjects and subjects with chronic renal failure. An assay using antibodies raised against recombinant ALS yielded lower apparent values than the other methods in patient sera, the discrepancy probably being attributable to a difference in standardization. We conclude that a variety of assay formats and reagents can yield serum ALS values of potential clinical utility.
引用
收藏
页码:271 / 279
页数:9
相关论文
共 31 条